Filing Details
- Accession Number:
- 0001487371-19-000188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-19 17:15:22
- Reporting Period:
- 2019-08-15
- Accepted Time:
- 2019-08-19 17:15:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1487371 | Genmark Diagnostics Inc. | GNMK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1203567 | C Kevin Oboyle | 5964 La Place Court Carlsbad CA 92008 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-15 | 2,200 | $6.51 | 102,112 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-16 | 16,150 | $6.51 | 85,962 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-15 | 25,000 | $6.00 | 110,962 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-08-15 | 18,050 | $6.00 | 129,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-15 | 23,365 | $6.42 | 105,647 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-08-15 | 16,870 | $6.42 | 88,777 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-08-15 | 25,000 | $0.00 | 25,000 | $6.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-08-15 | 18,050 | $0.00 | 18,050 | $6.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-28 | No | 4 | M | Direct | |
| 0 | 2020-05-28 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person in June 2019.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.53. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.54. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The Reporting Person was issued 1,635 shares of the Company's common stock pursuant to the net exercise of the designated stock options. As a result, the Company withheld 23,365 shares of common stock underlying the exercised stock options for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan.
- The Reporting Person was issued 1,180 shares of the Company's common stock pursuant to the net exercise of designated stock options. As a result, the Company withheld 16,870 shares of common stock underlying the exercised stock option for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan.
Billionaire Hedge Funds
